We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01808053
Recruitment Status : Completed
First Posted : March 8, 2013
Last Update Posted : January 7, 2014
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:
To adapt and refine the BodyGuardian remote health monitoring system to acquire ECG, Heart rate (HR), activity and breathing data, which will be integrated with weight, blood pressure and symptom data, in subjects in an independent living center, with wireless transmission of data to a central data analysis hub.

Condition or disease Intervention/treatment
Congestive Heart Failure Device: BodyGuardian remote health monitoring system

Detailed Description:
The elderly are facing an increasing prevalence of chronic disease and rapidly escalating healthcare costs threatening independent living. Congestive heart failure (CHF) is a growing health epidemic and is associated with significant morbidity, mortality and cost. Mayo Clinic and Preventice have developed a non-invasive, minimally obtrusive, interactive remote monitoring platform. It enables on-body monitoring and integration of ECG, heart rate, breathing, and activity, with measures of weight and blood pressure. It is designed as a platform for physician directed patient self-management. This technology may be useful in monitoring CHF patients. Our overall objective is to adapt, refine, test and validate this technology in subjects in an independent living center, with wireless transmission of data to a central data analysis hub.

Study Design

Study Type : Observational
Actual Enrollment : 20 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
Study Start Date : March 2013
Primary Completion Date : December 2013
Study Completion Date : December 2013
Groups and Cohorts

Group/Cohort Intervention/treatment
Healthy older and independently living adults
The BodyGuardian remote health monitoring system will used by healthy older and independently living adults
Device: BodyGuardian remote health monitoring system
The remote health management system connects personal health sensors with secure mobile communication devices. It is also able to give immediate feedback to the user. The solution is a multi-tiered mobile health platform. The front-end includes an adhesive snap-strip body sensor (BodyGuardian) that can measure HR, ECG, respiration rate (RR), and activity which is FDA approved for detection of non-lethal cardiac arrhythmias. It can wirelessly communicate with off-body sensors such as a BP cuff and scale to incorporate BP and weight data based on automated algorithms and can solicit symptoms from the user. It can also be used as an event recorder inputting symptoms and recording simultaneous physiologic data.


Outcome Measures

Primary Outcome Measures :
  1. Number of subjects with successful data transfer at the end of 30 day monitoring period. [ Time Frame: approximately at the end of 30 day monitoring period ]
    Data collected will be reviewed by engineering collaborators.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy older adults living at an independent living center.
Criteria

Inclusion Criteria:

  • Resident at independent living facility
  • Adequate phone service
  • Healthy with life anticipated survival >than one year

Exclusion Criteria:

  • Skin reaction/allergies to adhesives
  • Have implantable pacemaker and/or defibrillator or have a bed partner with an implantable pacemaker
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01808053


Locations
United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Preventice
Investigators
Principal Investigator: Charles J Bruce, MBChB Mayo Clinic
More Information

Responsible Party: Charles J. Bruce, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier: NCT01808053     History of Changes
Other Study ID Numbers: 12-008639
R01AG041676 ( U.S. NIH Grant/Contract )
First Posted: March 8, 2013    Key Record Dates
Last Update Posted: January 7, 2014
Last Verified: January 2014

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases